ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 197 filers reported holding ANI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,527 | +7.9% | 388 | 0.0% | 0.01% | +20.0% |
Q2 2023 | $20,886 | +96.9% | 388 | +45.3% | 0.01% | +66.7% |
Q1 2023 | $10,605 | -32.1% | 267 | -31.2% | 0.01% | -33.3% |
Q4 2022 | $15,609 | +30.1% | 388 | 0.0% | 0.01% | +12.5% |
Q3 2022 | $12,000 | 0.0% | 388 | 0.0% | 0.01% | +14.3% |
Q2 2022 | $12,000 | -33.3% | 388 | 0.0% | 0.01% | -22.2% |
Q4 2021 | $18,000 | +38.5% | 388 | 0.0% | 0.01% | +28.6% |
Q3 2021 | $13,000 | -7.1% | 388 | 0.0% | 0.01% | -12.5% |
Q2 2021 | $14,000 | 0.0% | 388 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $14,000 | +27.3% | 388 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $11,000 | -65.6% | 388 | -61.5% | 0.01% | -75.8% |
Q2 2020 | $32,000 | -50.0% | 1,008 | -35.9% | 0.03% | -59.3% |
Q1 2020 | $64,000 | -61.2% | 1,572 | -30.5% | 0.08% | -24.3% |
Q3 2019 | $165,000 | -11.3% | 2,261 | 0.0% | 0.11% | -14.4% |
Q2 2019 | $186,000 | +32.9% | 2,261 | +14.2% | 0.12% | +16.8% |
Q1 2019 | $140,000 | -7.9% | 1,980 | -26.3% | 0.11% | +46.6% |
Q3 2018 | $152,000 | – | 2,686 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |